Supernus Pharmaceuticals SUPN Business Segments — General and administrative expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's business segments — general and administrative expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Supernus Pharmaceuticals's business segments — general and administrative expenses?
- Supernus Pharmaceuticals (SUPN) reported business segments — general and administrative expenses of $38.2M in Q1 2026.
- How has Supernus Pharmaceuticals's business segments — general and administrative expenses changed year-over-year?
- Supernus Pharmaceuticals's business segments — general and administrative expenses increased by 43.2% year-over-year, from $26.67M to $38.2M.
- What is the long-term trend for Supernus Pharmaceuticals's business segments — general and administrative expenses?
- Over 3 years (2022 to 2025), Supernus Pharmaceuticals's business segments — general and administrative expenses has grown at a 4.6% compound annual growth rate (CAGR), from $109.43M to $125.36M.
- What does business segments — general and administrative expenses mean?
- Encompasses the overhead costs required to support the segment's operations, including management, legal, and administrative functions. Tracking these expenses provides insight into the company's operational leverage and cost management discipline.